Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
DL-Homocystine is an oxidized dimeric form of homocysteine (Item No. 30285). It inhibits CDNB-induced L-cystine (Item No. 31727) transport into isolated human erythrocytes by 75% when used at a concentration of 2.5 mM.1 DL-Homocystine increases the number of circulating endothelial cells and permeability of the pulmonary microcirculation and decreases the number of circulating platelets, as well as activates venostatic thrombosis induced by bowel loop ligation in a rat model of homocystinemia, an inborn error of metabolism characterized by a deficiency in cystathionine β-synthase (CBS) that is associated with thrombosis and atherosclerosis.2
WARNING This product is not for human or veterinary use.
1. Oxidative stresses induced the cystine transport activity in human erythrocytes. Biochem. Biophys. Res. Commun. 155(1), 160-166 (1988).
2. Experimental homocystinemia, endothelial lesions and thrombosis. Blood Vessels 16(4), 202-205 (1979).